IFNG and tuberculosis: T-SPOT®.TB, approved by the U.S. Food and Drug Administration (FDA) in 2008, is an enzyme-linked immunospot-based assay (ELISPOT) that measures the number of cells that release IFN-γ upon stimulation with Mtb Ags [63].